Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge assists SJ with financing from NIB
Mandate

Vinge assists SJ with financing from NIB

April 22, 2009

Vinge has advised SJ AB in connection with a financing transaction in which SJ is borrowing approximately SEK 500,000,000 (MEUR 45) from the Nordic Investment Bank (NIB) in order to partly finance 20 new high-speed trains. The new trains will constitute the base for SJ’s new traffic system and will be delivered during 2010.

”NIB imposes stringent demands for granting loan facilities and SJ had a significant advantage as a result of the positive environmental aspects which flow from development of, and investment in, train services in Sweden” says Fredrik Wilkens, partner at Vinge.

Vinge’s team consisted of responsible partner Fredrik Wilkens and associates Emma Stuart-Beck and Katarina Rykowska.

Related

Vinge advises OsteoCentric on the public offer for Integrum

 OsteoCentric Oncology and Bone Anchored Prostheses, LLC, a subsidiary of OsteoCentric Technologies, Inc., has made a public offer for all shares in Integrum AB (publ). The offer values all shares in Integrum at approximately SEK 939 million.
July 23, 2025

Vinge advises Investor on its co-investment in the SEK 55 billion public offer for Fortnox led by EQT X

 Vinge advises Investor AB (publ) (“Investor”) on its co-investment in the public offer for Fortnox AB (publ) (“Fortnox”) led by EQT X together with First Kraft AB (owned by Olof Hallrup), acting through Omega II AB (“Omega II”). Fortnox offers vital software infrastructure to small and medium-sized companies in Sweden with a track record of profitable growth.
July 22, 2025

Vinge advises Cantargia in connection with the sale of immunology program CAN10

 Vinge advises Cantargia AB (publ) in connection with the sale of its early-clinical stage IL1RAP immunology program CAN10 to the Japanese healthcare company Otsuka Pharmaceutical.
July 21, 2025